Infrainguinal vein bypass graft revision: Factors affecting long-term outcome  by Nguyen, Louis L. et al.
From the Society for Vascular Surgery
Infrainguinal vein bypass graft revision: Factors
affecting long-term outcome
Louis L. Nguyen, MD, MBA, Michael S. Conte, MD, Matthew T. Menard, MD, Edwin C. Gravereaux,
MD, David K. Chew, MD, Magruder C. Donaldson, MD, Anthony D. Whittemore, MD, and Michael
Belkin, MD, Boston, Mass
Objectives: We sought to determine the long-term results of revision procedures performed for repair of stenotic lesions
in infrainguinal vein bypass grafts.
Methods: A retrospective review of 188 vein grafts, from a total series of 1260 bypasses, undergoing revision of stenotic
lesions between January 1, 1987, and December 31, 2002, at Brigham & Women’s Hospital was undertaken. Lesions
were identified by recurrence of symptoms, change in examination findings, or with routine duplex ultrasound graft
surveillance. Demographic and medical risk factors, and surgical variables were analyzed with respect to patency outcomes
after the initial graft revision, with descriptive statistics, logistic regression, and life table analysis. Primary and secondary
patency rates were determined from the time of graft revision.
Results: Patients included 108 men (57%) and 80 women (42%) who underwent revision at a mean age of 67.8 years. One
hundred thirty grafts required only a single revision, whereas 58 required subsequent additional revisions. Revision
procedures included 99 vein patches (52.7%), 23 jump grafts (12.2%), 23 interposition grafts (12.2%), 8 transpositions
to new outflow vessels (4.3%), and 35 balloon angioplasty procedures (18.6%). During a mean follow-up of 1535 days,
5-year primary patency rate was 49.3%  4.5% (SE) and 5-year secondary patency rate was 80.3%  3.6%. There was no
difference in patency rate for different revision procedures, type of vein graft, indication for the original procedure, or for
patients with diabetes mellitus or renal disease. The overall limb salvage rate was 83.2% 3.5% 5 years after graft revision.
With COX proportional hazard analysis of time to failure of the revision procedure, the outflow level of the original
bypass and the time of revision proved to be an important predictor of durability of the graft revision. Revision of
popliteal bypass grafts resulted in a 60% 5-year primary patency rate, whereas revision of tibial grafts resulted in a 42%
5-year primary patency rate (P  .004; hazard ratio [HR], 2.06). Five-year secondary patency rates were 90% and 76%,
respectively (P .009; HR 3.43). The timing of the graft revision proved an additional predictor. Grafts revised within
6 months of the index operation had lower primary patency than those with later revisions (42.9% vs 80.7%, respectively;
HR  1.754; P  .0152).
Conclusions: Vein graft revisions offer durable patency and limb salvage rates after repair of stenotic infrainguinal bypass
grafts. Vigilant ongoing surveillance is essential, because 30.9% of revised grafts will develop additional lesions that will
require repair. Tibial level bypass grafts that require early repeat intervention to treat graft stenosis are at particular risk
for development of subsequent lesions. ( J Vasc Surg 2004;40:916-23.)Infrainguinal bypass is a well-established therapeutic
option in patients with disabling claudication or threatened
limb loss. The use of autogenous vein as a bypass conduit
has been associated with improved patency results, com-
pared with prosthetic conduits. Nevertheless, vein graft
failure remains a significant problem. Early graft failure, less
than 30 days after surgery, is often attributed to technical
problems, and has been reported in 5% to 20% of cases.
Intermediate graft failure, 30 days to 2 years after surgery,
and late graft failure, more than 2 years after surgery, can
occur in 20% to 50% of cases at 5 years.1 Whether grafts
behave differently after revision compared with grafts that
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916do not need revision is controversial. Some authors report
little difference between revised grafts and primary grafts,2
whereas others report worse patency rates (69% at 5 years)
with revised grafts compared with nonrevised grafts (81% at 5
years).3 The optimal method of graft revision is also debated.
Several authors have found evidence to suggest that some
methods offer superior patency rates than others do.2,4,5
Graft surveillance in the postoperative period is useful
in identifying threatened grafts so that intervention can be
performed before graft thrombosis occurs.6,7 Thrombosed
vein grafts that are salvaged have a 22.9% 3-year secondary
patency rate, and 60.3% limb salvage at 3 years.8 Revision of
failing grafts results in better 2-year patency (81%) and limb
salvage (77%) than thrombolysis or thrombectomy of
thrombosed grafts (7% and 44%, respectively).9 Thrombol-
ysis may have a role in patients with mature grafts and who
have no options for autogenous revascularization.10
Despite the widespread recognition of the importance
of vein graft surveillance and preemptive revision of ste-
notic grafts, the natural history of such revisions is not well
described. We sought to determine factors that affect the
patency of infrainguinal vein graft revisions and the subse-
quent need for multiple revisions.
or co
2.
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A retrospective review from a prospectively collected
database was performed of lower extremity arterial bypass
vein grafts that underwent revision at Brigham&Women’s
Hospital between January 1, 1987, and December 31,
2002. Grafts with technical complications requiring imme-
diate revision (1 week) were excluded from the study.
Grafts revised after thrombectomy or thrombolysis also
were excluded. Demographic data, medical risk factors, and
surgical variables were analyzed with regard to patency after
the initial graft revision. Graft lesions were identified by
recurrence of ischemic symptoms, change in findings at
physical examination, or with routine duplex ultrasound
graft surveillance. For the study group, 156 patients (83%)
underwent graft scanning at least once after the revision; 32
(17%) did not. This is similar to our follow-up compliance
rate of 75% for all patients after bypass, starting in 1990.
Duplex scan findings of increased absolute velocity (300
cm/s), velocity ratio of 3:1, or low flow (30 cm/s) in an
otherwise normal-sized graft were used as criteria for fur-
ther graft investigation. Most grafts with stenosis detected
with routine surveillance duplex scanning subsequently
underwent further imaging with angiography or magnetic
resonance angiography. Only in selected cases did grafts
not undergo further imaging, and instead proceeded to
revision on the basis of findings duplex scans. Our general
practice is to revise grafts according to the anatomic char-
acteristics of the stenosis. Short focal stenoses (4 cm)
were repaired with vein patch angioplasty; long segment
stenoses (4 cm) were repaired with an interposition graft;
long segments that approached the anastomosis were re-
paired with a jump graft to the native vessel; transposition
Table I. Demographic data for graft revision patients
Overall Single re
Number of grafts 188 130 (
Gender
Male 108 (57.4%) 75 (
Female 80 (42.6%) 55 (
Age*
Mean 67.8 6
Median 69 6
Comorbidities
Diabetes 115 (61.2%) 76 (
Smoking 61 (32.4%) 43 (
Hypertension 123 (65.4%) 82 (
CAD† 105 (55.8%) 75 (
Prior CABG 49 (26.1%) 36 (
Stroke 23 (12.2%) 14 (
COPD 22 (11.7%) 19 (
CRI‡ 28 (14.9%) 23 (
No dialysis 12 (6.4%) 9 (
Dialysis 16 (8.5%) 14 (
CHF 17 (9%) 12 (
Arrhythmia 17 (9%) 13 (
*Age at time of index surgery.
†CAD  coronary artery disease; defined as history of myocardial infarction
‡CRI  chronic renal insufficiency; defined as serum creatinine greater thangrafts connected the bypass to a different vessel target; andballoon angioplasty was used for focal lesions (1.5 cm)
with segments of normal caliber vein proximal and distal.
Vein grafts found to have diffuse intimal hyperplasia with
narrowed caliber were generally aborted in favor of a new
autogenous bypass, when indicated.
Demographic and medical risk factors, and surgical
variables were analyzed with descriptive statistics (mean, X2
test for bivariates; Student t test for comparison of paramet-
ric means) to compare single revision versus multiple revi-
sion groups. Comparisons of graft primary patency, sec-
ondary patency, and limb salvage were made with logistic
regression and life table analysis, with a Cox proportional
hazards model. Primary and secondary patency rates were
determined from the time of graft revision. Patency results
are expressed as percent  SE.
The project was reviewed and approved by the Brigham
& Women’s Hospital Institutional Review Board, assur-
ance No. FWA00000484.
RESULTS
Demographic data and descriptive statistics.
Between January 1, 1987, and December 31, 2002, 1260
patients underwent 1629 infrainguinal bypass procedures
with autogenous vein. Of those patients, 175 patients with
188 grafts (11.5%) underwent a single revision (N  130;
69.1%) or multiple revisions (N  58; 31%) performed in
separate procedures. In the multiple revision group, 43
patients underwent 2 revisions, 7 patients underwent 3
revisions, and 8 patients underwent 4 revisions. The 188
revised grafts served as our study group. For grafts with
multiple revisions, the first revision was considered the
(SR) Multiple revisions (MR) P value
%) 58 (30.9%)
%) 33 (56.9%) 0.919
%) 25 (43.1%) 0.919
68.1 0.809
69.5
%) 39 (67.2%) 0.254
%) 18 (31%) 0.782
%) 41 (70%) 0.311
%) 30 (51.7%) 0.447
%) 13 (22.4%) 0.446
%) 9 (15.5%) 0.359
%) 3 (5.2%) 0.047
%) 5 (8.6%) 0.078
) 3 (5.2%) 0.078
%) 2 (3.4%) 0.078
) 5 (8.6%) 0.567
4 (6.9%) 0.351
ronary bypass.vision
69.1
57.7
42.6
7.7
8.5
58.5
33.1
63.1
57.7
27.7
10.8
14.6
17.7
6.9%
10.8
9.2%
10%)reference revision for the study.
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were women; their mean age was 67.8 years (Table I).
Patients had comorbid conditions typical in patients with
peripheral vascular disease, including diabetes (61.2%),
smoking (current or within 1 year of surgery, 32.4%),
hypertension (65.4%), coronary artery disease (55.8%), pre-
vious coronary artery bypass grafting (26.1%), stroke
(12.2%), chronic obstructive pulmonary disease (COPD;
11.7%), chronic renal insufficiency (14.9%), congestive
heart failure (9%), and arrhythmia (9%).
Indications for the index bypass were life style–limiting
claudication (17.6%) and limb salvage (82.4%). Among
patients in the limb salvage group, 58% had tissue loss, and
rest pain was an indication in 42%. The most common site
of proximal anastomosis was the common femoral artery
(68.1%), followed by the superficial femoral artery (20.2%),
popliteal artery (9.6%), and profunda femoris artery (2.1%).
The most common site of distal anastomosis was the tibial
or pedal arteries (62.2%), and the popliteal artery was the
site in 37.8%. Conduits used were in situ greater saphenous
vein (31.4%), nonreversed greater saphenous vein (31.4%),
reversed greater saphenous vein (8%), arm vein (6.9%), and
lesser saphenous vein (2.1%). Composite vein grafts (leg-
with-leg vein or arm-with-leg vein) made up 20.2% of
conduits used. Of the 188 revised grafts 110 (58.5%) had
stenosis only in the body of the graft, 55 (29.3%) had
stenosis at an anastomotic site, and 23 (12.2%) had lesions
both in the graft and at an anastomosis. In patients who
subsequently required a second revision, 30 patients
(51.7%) had the second revision at the same site as the first
revision, and 28 patients (48.3%) had the revision at an-
other site. Initial revision location was not associated with
the site of second revision (Table II, online only).
Of the 130 single revision grafts, 19 (14.6%) became
thrombosed sometime after the first, and only, revision.
Three had attempts at thrombectomy, but only 1 was
patent over the long term (498 days). Of the 58 multiple
revision grafts, 8 (13.8%) became thrombosed sometime
after the second revision. Thrombectomy was performed in
only 1 graft, which remained patent for 407 days. Throm-
bolysis was performed in another graft, but long-term
patency was not achieved.
Several techniques were used to revise the index graft,
according to anatomic factors, including patch angioplasty
(52.7%), balloon angioplasty (18.6%), jump graft (12.2%),
interposition graft (12.2%), and graft transposition (4.3%).
When grafts were revised at more than 1 site (N  45,
23.9%) at the same operation, the most severe lesion was
considered the reference lesion for our study. There was no
statistical difference in primary patency and secondary pa-
tency between grafts revised at only 1 site and grafts with
multiple sites of revision (46.0%  5.2% vs 58.8%  8.5%
[5-year primary patency], P .10; 80.8% 4.2% vs 78.0
6.5% [5-year secondary patency], P  .359). Mean fol-
low-up for all grafts was 51.2 months (median, 39.8
months; range, 2.3-188.7 months).
Comparative statistics. Compared with the single re-
vision group, the multiple revision group did not differsignificantly in age (t-test) or gender (X2 test). Similar
findings were also true of risk factors such as diabetes,
smoking, hypertension, coronary artery disease, coronary
artery bypass grafting, stroke, chronic renal insufficiency,
congestive heart failure, and arrhythmia (Table I) Only
COPD was statistically significantly less common in pa-
tients with 2 or more revisions (P  .047).
Mean follow-up from time of index procedure was 51.2
months overall (median, 39.8 months; range, 2.3-188.7
months). single revision grafts had a shorter mean fol-
low-up of 46.9 months (median, 29.3 months; range,
2.3-185.4 months) compared with multiple revision grafts,
with mean follow-up of 60.7 months (median, 55.5
months; range, 8.7-188.7 months; P  .042).
No statistically significant differences were found be-
tween the single revision and multiple revision groups with
regard to indication for the index operation (claudication,
limb salvage), site of proximal anastomosis (common fem-
oral artery, superficial femoral artery, profunda femoris
artery, popliteal artery), site of distal anastomosis (popliteal
artery, tibioperoneal trunk, anterior tibial artery, posterior
tibial artery, peroneal artery, dorsalis pedis artery), or graft
conduit (in situ greater saphenous vein, nonreversed
greater saphenous vein, reversed greater saphenous vein,
arm vein, lesser saphenous vein, composite vein; Table III).
The type of revision for each graft was chosen by the
operating surgeon according to the nature and position of
the lesion and the availability of autogenous vein. No
statistically significant differences were found between sin-
gle revision andmultiple revision groups with regars to type
of first revision (patch, jump graft, interposition graft,
transposition graft, balloon angioplasty; Table IV) For
grafts that underwent a second revision, only balloon an-
gioplasty at initial revision showed an association with the
need for second revision at the same site (P  .007; Table
V, online only).
Graft patency and life table analysis. Mean time
from index procedure to graft stenosis was 345 days (me-
dian, 175 days; range, 3-3766 days), and there was no
significant difference between the single revision and mul-
tiple revision groups (Table IV). For the 188 revised grafts,
5-year primary patency from the time of graft revision was
49.3%  4.5%, and secondary patency from the time of
graft revision was 80.3%  3.6% (Fig 1). To assess the
effectiveness of graft revision on overall graft patency, we
also determined the patency rate from the time of index
graft placement. These results were similar in that at 5 years
primary patency and secondary patency from the time of
index bypass were 52.9%  4.4% and 84.4%  3.0%,
respectively.
For grafts revised with patch angioplasty (N  99),
5-year primary patency was 53.2%  6.4%, and secondary
patency was 83.5%  4.6% (Table VI) . For grafts revised
with a jump graft (N  23), 5-year primary patency was
32.2%  13.1%, and secondary patency was 73.4% 
12.6%. For grafts revised with interposition grafts (N 
23), 5-year primary patency was 39% 12.4%, and second-
ary patency was 65.6%  15.2%. For grafts revised with
da fem
9-3
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57.1%  18.7%, and secondary patency was 85.7% 
13.2%. For grafts revised with balloon angioplasty (N 
35), 5-year primary patency was 48.1%  9.3%, and sec-
ondary patency was 84.5%  6.4%. Individually, the graft
revision methods showed no significant differences in
5-year primary patency and secondary patency when com-
pared with each other (Table V). Because some subgroups
had small numbers, we also performed patency compari-
sons between 2 broad groups: focal revision (patch angio-
plasty, balloon angioplasty) versus segment revision (inter-
position graft, transposition graft, jump graft). The 5-year
rates did not differ between these groups. Primary patency
in the focal revision group was 52.2%  5.3%, and in the
Table III. Index operation
Overall Single
Indication
Claudication 33 (17.6%) 2
Limb salvage 155 (82.4%) 10
Rest pain 65 (34.6%) 4
Tissue loss 90 (58.1%) 6
Ulceration 61 (32.4%) 3
Gangrene 29 (15.4%) 2
Proximal anastomosis
CFA 128 (68.1%) 9
SFA 38 (20.2%) 2
Proximal SFA 27 (14.4%) 1
Distal SFA 11 (5.8%) 1
PFA 4 (2.1%)
Popliteal 18 (9.6%) 1
Distal anastomosis
Popliteal 71 (37.8%) 5
Proximal 27 (14.4%) 2
Distal 44 (23.4%) 3
Tibial/pedal 117 (62.2%) 7
Graft conduit
In situ GSV 59 (31.4%) 3
NR GSV 59 (31.4%) 4
Reversed GSV 15 (8.0%) 1
Arm vein 13 (6.9%)
LSV 4 (2.1%)
Composite vein 38 (20.2%) 2
CFA, Common femoral artery; SFA, superficial femoral artery; PFA, profun
dorsalis pedis.
Table IV. Graft revisions
Overall Sing
Type of Revision
Patch 99 (52.7%)
Jump graft 23 (12.2%)
Interposition 23 (12.2%)
Transposition 8 (4.3%)
Angioplasty 35 (18.6%)
Time to graft stenosis (days)
Mean 344.7
Median 175
Range 3-3766segment revision group was 40.1%  8.1% (P  .106).Secondary patency in the focal revision group was 83.8%
3.7%, and in the segment revision group was 71.7% 9.0%
(P  .107).
The limb salvage rate for legs with graft revisions (N
188) was 83.2%  3.5% at 5 years. Patient survival rate
(N 175) was 56.8% 4.7% at 5 years. For single revision
grafts (N  130), 5-year primary patency was 77.2% 
4.6%, and secondary patency was 79.1%  4.6%. For mul-
tiple revision grafts (N 58), secondary patency was 82.8%
 5.7%.
Univariate analysis was performed on the aforemen-
tioned demographic, medical, and surgical factors with
respect to graft patency. The site of distal anastomosis
(popliteal vs tibial or pedal; P  .0041) and time of first
on (SR) Multiple revisions (MR) P value
.2%) 8 (13.8%) 0.246
.8%) 50 (86.2%) 0.365
.6%) 20 (34.5%) 0.562
.1%) 30 (60.0%) 0.480
.0%) 22 (37.9%) 0.183
.2%) 8 (13.8%) 0.430
.2%) 38 (65.6%) 0.366
.0%) 12 (20.7%) 0.529
.3%) 11 (19.0%) 0.229
%) 1 (1.7%) 0.095
%) 2 (3.4%) 0.363
%) 6 (10.3%) 0.342
.5%) 17 (29.3%) 0.110
.2%) 6 (10.3%) 0.207
.3%) 11 (19.0%) 0.662
.5%) 41 (70.7%) 0.110
.0%) 20 (34.5%) 0.541
.5%) 18 (31.0%) 0.945
%) 5 (8.6%) 0.828
%) 5 (8.6%) 0.369
%) 1 (1.7%) 0.637
.3%) 9 (15.6%) 0.192
oris artery; TP, tibioperoneal; AT, anterior tibial; PT, posterior tibital; DP,
ision (SR) Multiple revisions (MR) P value
6.9%) 25 (43.1%) 0.080
0.8%) 9 (15.5%) 0.246
1.5%) 8 (13.8%) 0.414
.9%) 3 (5.2%) 0.471
6.9%) 13 (22.4%) 0.055
0.6 286.4 0.365
0 154 0.083
766 3-2437revisi
5 (19
5 (80
5 (34
0 (57
9 (30
1 (16
0 (69
6 (20
6 (12
0 (7.7
2 (1.6
2 (9.2
4 (41
1 (16
3 (25
6 (58
9 (30
1 (31
0 (7.7
8 (6.2
3 (2.3
9 (22le rev
74 (5
14 (1
15 (1
5 (3
22 (1
37
18revision (6 months vs 6 months from index procedure;
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cant effect on revision primary patency. Multivariate analy-
sis and Cox proportional hazard modeling were performed
for the significant univariate variables (site of distal anasto-
mosis, time to first revision), and were found to also be
significant. Grafts with tibial or pedal distal anastomosis
(5-year primary patency, 43.4%  5.6%; 5-year secondary
patency, 73.6%  5.1%) were at greater risk for primary
failure than were grafts with popliteal distal anastomosis
(5-year primary patency, 59.5%  7.3%; 5-year secondary
patency, 90.3%  4.3%; primary patency hazard ratio
[HR], 2.051; P  .0053; secondary patency HR  3.426;
P .0136; Fig 2) Grafts that were revised within 6 months
of the index operation (5-year primary patency, 42.9% 
6%) were at greater risk for primary failure than were grafts
with later revisions (5-year primary patency, 56.8% 6.6%;
HR 1.754; P .0152). Secondary patency rates between
these 2 subgroups did not differ statistically (80.7% 4.6%
vs 79.5%  5.6%, respectively; Fig 3).
DISCUSSION
Despite advances in surgical technique, infrainguinal
vein graft failure occurs in 20% to 50% of cases, and remains
a major problem for vascular surgeons and our patients.
Rescue of the thrombosed vein graft with thrombectomy
or thrombolysis usually does not result in restoration of
durable patency.8,10 Furthermore, replacement of a failed
bypass graft with a new bypass graft poses a variety of
challenges to the surgeon, including scarring, shortage of
autogenous vein, and increased patient comorbidy. Thus
the results of repeat bypass surgery after failed bypass are
inferior to those of primary bypass surgery.1,11 It is there-
fore imperative to maintain the patency of infrainguinal
bypass grafts. Routine surveillance of bypass grafts with
close clinical follow-up and serial duplex ultrasound scan-
ning of the graft has become the standard of care in lower
extremity bypass surgery.
The duplex scan is highly sensitive and specific for
identifying lesions that threaten vein graft patency.11,12
The most common lesion appears, or progresses, during
the early postoperative period, and results from intimal
hyperplasia that forms at a valve site, an anastomosis, a
venovenostomy site, or within the graft body. Lesions
Fig 1. Primary and secondary patency of revised grafts.appearing during the late postoperative period (2 years)often are atherosclerotic, and occur with the vein graft
proper or in the inflow or outflow arteries. Once identified,
these lesions are managed with a variety of surgical and
endovascular techniques. Despite the widespread recogni-
tion that graft revision is an important component of graft
maintenance, the long-term results of this approach have
not been well-delineated.13 This study was undertaken to
evaluate the natural history of the revised vein graft. More
specifically, we were interested in whether certain revision
procedures are more effective than others in maintaining
graft patency, and whether there are any operative or pa-
tient-related variables that would predict the need for sub-
sequent revisions.
The overall results of 49.3%  4.5% 5-year primary
patency and 80.3%  3.6% secondary patency from the
time of graft revision are similar to the results of 52.9% 
4.4% 5-year primary patency and 84.4%  3.0% secondary
patency from the time of the index bypass. This is quite
encouraging, and confirms that durable patency may be
achieved through revision of stenosed grafts. In patients in
whom the original bypass grafting was performed for limb
salvage, vein graft revisions also resulted in prolonged limb
salvage rates of 83.2%  3.5% at 5 years after revision.
These results are similar to those achieved by others. For
example, Bandyk et al2 found a cumulative graft revision
patency rate of 96% at 1 year and 85% at 5 years in their
series of 83 femoral distal saphenous vein bypasses. Mills et
al12 reported an 82% assisted primary patency rate at 5 years
in their series of 32 grafts with intermediate stenosis (200
cm/s  peak systolic velocity  300). Landry et al14
reported 87.4% 5-year secondary patency and 88.7% 5-year
limb salvage in their series of 330 graft revisions.
It has been our routine to tailor the mode of revision to
the patient’s surgical anatomy. Our policy, with rare excep-
tion, is to complete all revisions with autogenous vein. A
short segmental vein patch constituted more than 50% of
our revision procedures, with various forms of jump and
interposition grafts making up the remaining surgical pro-
cedures. Many such procedures require the use of ectopic
vein. Balloon angioplasty was used in 18.6% of cases, and is
reserved for short segment lesions with flanking segments
of normal caliber vein. It is reassuring that all of the various
forms of revision procedures offer similar patency rates,
ranging from 73.2%  11.1% to 84.5%  6.4% at 5 years
after revision (Table VI). These results differ slightly from
those of others, such as Bandyk et al,2 who found that
treatment of residual valve sites or focal myointimal lesions
with excision of the vein and primary reanastomosis re-
sulted in no recurrent stenosis, whereas 24% of lesions
treated with vein patch angioplasty developed recurrent
stenosis at the revision site (range of follow-up, 3-72
months). Decisions regarding postoperative anticoagula-
tion were made by the operating surgeon on an individual
case basis. Because many patients have other medical con-
ditions that already dictate the need for anticoagulation, no
clear association can be made between postoperative anti-
coagulation and graft outcomes.
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tion. Our initial experience with balloon angioplasty sug-
gested a limited role for this treatment method, with an
18% cumulative 5-year patency rate.15 Similar results have
been reported by others.5,16,17 We also found grafts ini-
tially revised with balloon angioplasty were more likely to
require revision at the same anatomic site, if they needed a
second revision. With improvements in technique and pa-
tient selection, we are encouraged by the improved results
Table VI. Cumulative patency rates for revision type
1 Year 2 Year
Patch angioplasty
PP 74.5  4.7% 61.2  5.2%
SP 90.6  3.2% 87.7  3.7%
Jump graft
PP 57.3  11.7% 43.0  12.4%
SP 84.7  8.2% 84.7  8.2%
Interposition
PP 61.0  10.9% 54.6  11.5%
SP 95.4  4.5% 78.8  11.3%
Transposition
PP 57.1  18.7% 57.1  18.7%
SP 85.7  13.2% 85.7  13.2%
Balloon angioplasty
PP 63.7  8.4% 56.6  8.9%
SP 84.5  6.4% 84.5  6.4%
PP, Primary patency; SP, secondary patency.
Fig 2. Primary and secondary revision graft patency for popliteal
versus tibial or pedal distal anastomosis sites.
Fig 3. Primary graft revision patency for grafts revised less than 6
months versus greater than 6 months after index operation.achieved in this updated series, with 48.1% 9.3% primarypatency and 84.5%  6.4% secondary patency 5 years after
balloon angioplasty of stenotic grafts. These numbers are
more in keeping with the recent literature. Carlson et al18
reported 5-year 58.2% primary patency and 78.9% second-
ary patency in their series of 45 angioplasties. An additional
potential advance is the application of cutting balloon
technology, which in theory may enable incision and more
effective dilation of the fibroelastic intimal hyperplastic
lesions characteristic of vein grafts. An early report showed
only 1 of 19 grafts with persistent increased velocity at
duplex scanning during a mean follow-up of 11.4
months.19 Our own experience with this approach is too
early to corroborate these observations. Despite the im-
provements in results with balloon angioplasty of stenotic
grafts, we continue to believe it is best used selectively and
that most lesions are best treated surgically. Too aggressive
application of this technique, particularly in small-caliber
vein grafts or longer lesions, can result in graft damage or
thrombosis, and seldom yields durable patency.
Despite the patency rates achieved in this series, it is
remarkable that 58 of 188 grafts (30.9%) required a second
or third graft revision to treat additional lesions that devel-
oped during follow-up after the primary graft revision. This
finding highlights the need for ongoing aggressive graft
surveillance after the initial graft revision. Graft surveillance
and subsequent (additional) graft revision is worthwhile,
because we found that secondary patency rates for multiple
revision grafts (82.8%  5.7%) are comparable to those of
single revision grafts.
We examined a number of characteristics that might
enable identification of grafts that will require multiple
revision procedures. Patient gender, age, indication for
surgery, and vein graft conduit type were not predictive.
Among the various patient comorbid conditions examined,
only COPD was slightly associated with increased need for
multiple revisions (perhaps a spurious association). Among
operative factors there was a tendency for patch angioplasty
to be associated with single revision, and balloon angio-
3 Year 4 Year 5 Year
60.4  5.7% 53.2  6.4% 53.2  6.4%
87.7  3.7% 83.5  4.6% 83.5  4.6%
32.2  13.1% 32.2  13.1% 32.2  13.1%
73.4  12.6% 73.4  12.6% 73.4  12.6%
39.0  12.4% 39.0  12.4% 39.0  12.4%
78.8  11.3% 65.6  15.2% 65.6  15.2%
57.1  18.7% 57.1  18.7% 57.1  18.7%
85.7  13.2% 85.7  13.2% 85.7  13.2%
52.4  9.1% 48.1  9.3% 48.1  9.3%
84.5  6.4% 84.5  6.4% 84.5  6.4%plasty with multiple revisions, though no statistical signifi-
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had significantly lower 5-year primary patency rates after
graft revision than those to the popliteal artery (59.5% 
7.3% vs 43.4%  5.6%). This may be simply explained by
longer segments of graft at risk for new lesions to develop,
although other, more complex mechanisms may be in-
volved as well. Similarly, grafts that required revision be-
cause of early lesions (6 months from index graft place-
ment) were more likely to require an additional revision
procedure. Such early grafts are likely undergoing their
initial revisions at a time when they are biologically active
and other lesions are at nascent stages. Conversely, grafts
that require revision later are more likely quiescent, with
only an isolated lesion.
Vigilant graft surveillance is essential throughout the
life of an infrainguinal vein graft. A variety of revision
procedures, tailored to the patients’ pathologic anatomy,
are effective in restoring durable patency. Long segment
bypass to the tibial or pedal vessels, particularly those
requiring early graft revision, are at particular risk for re-
quiring additional revision procedures during subsequent
follow-up.
We thank Julie Lombara for assistance with the vascular
surgery registry, and Peter Gaccione for biostatistical con-
sultation.
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Dr R. Clement Darling III (Albany, NY). First of all, how do
your results with nonrevised vein grafts compare with this group?
And does the fact that a third of your group was not greater
saphenous veins, do you think that affected your long-term pa-
tency?
Second, although not statistically significant, why do you
believe that the jump graft revisions had a 32% primary patency rate
as compared with the rest of the bypasses?
Third, more than half of your lesions were focal. Patch and
balloon angioplasty had comparable patency. At least in our expe-
rience, we’ve had a difficult time figuring out which lesions would
be best and most amenable to balloon angioplasty in this series.
Could you please elucidate on which ones you chose, and did you
think that patch angioplasty is the preferred treatment, or should
we be moving on to balloon angioplasty as the primary therapy forLast, in your 2 high-risk groups, distal level anastomosis and
those with early failures, were more composite vein grafts and
secondary vein conduits or other demographic factors an influence
on your long-term patency, and do you think this contributed to
their failure?
Dr Louis L. Nguyen. Our previous work has shown a 74%
secondary patency rate at 5 years for all vein grafts done during the
same time period. However, we did not look at the patency rates of
only the nonrevised grafts. In previous work, we have also shown
slightly lower patency rates for composite vein grafts, which in-
cluded non-saphenous sources. So their inclusion in our study
group lowers the patency rates. However, since our study is a
retrospective cohort study, their inclusion reflects the patient mix
at our institution.
One possible explanation for the nonsignificant lower patency
rate for jump grafts is that there is a problem with not only the vein
JOURNAL OF VASCULAR SURGERY
Volume 40, Number 5 Nguyen et al 923graft but also the native artery, and that could contribute to a lower
patency result.
We reserve balloon angioplasty for very focal (1.5 cm)
lesions with surrounding good vein. There have been recent earlywith cutting balloon technology is limited, so we can’t make a
formal comment on that.
The effects of early revision and distal level of anastomosis
were significant at multivariate analysis, so the potential confound-results with cutting balloons by other institutions. Our experience ers were already controlled for.
Table II, online only. Second graft revision by site of
first graft revision
Same site Different site P value
Site of First Revision
Anastamosis Only 7 6 0.557
Graft Only 20 18 0.554
Anastamosis & Graft 3 4 0.460
First Revision Method
Patch Angioplasty 13 12 0.590
Jump Graft 3 6 0.201
Interposition graft 3 7 0.122
Transposition graft 0 1 0.483
Balloon angioplasty 11 2 0.007
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Table V, online only. P value for comparison between
5-year PP and SP patency rates of revision methods
Patch Jump Interposition Transposition Balloon
Patch 0.075 0.154 0.421 0.326
0.227 0.129 0.436 0.448
Jump 0.352 0.138 0.161
0.345 0.251 0.218
Interposition 0.209 0.278
0.159 0.081
Transposition 0.334
0.468
Balloon
PP is top number, SP is bottom number.
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